COVID-19 in adult acute myeloid leukemia patients a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) /
Patients with acute myeloid leukemia (AML) are at high risk of dying from coronavirus disease 2019 (COVID-19). The optimal management of AML patients with COVID-19 has not been established. Our multicenter study included 388 adult AML patients diagnosed with COVID-19 between February 2020 and Octobe...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2023
|
| Sorozat: | HAEMATOLOGICA
108 No. 1 |
| Tárgyszavak: | |
| doi: | 10.3324/haematol.2022.280847 |
| mtmt: | 33709057 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/26780 |